# A Relative Bioavailability Study of 60 mg Nifedipine ER Tablets Under Non-fasting Conditions

> **NCT00864617** · PHASE1 · COMPLETED · sponsor: **Actavis Inc.** · enrollment: 84 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Nifedipine Extended Release tablets 60 mg, single dose
- **DRUG:** ADALAT® CC Extended Release Tablets 60 mg

## Key facts

- **NCT ID:** NCT00864617
- **Lead sponsor:** Actavis Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2010-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00864617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00864617, "A Relative Bioavailability Study of 60 mg Nifedipine ER Tablets Under Non-fasting Conditions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00864617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*